Phyllis Chan
Impact in
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 14
- Cancer Immunotherapy and Biomarkers 8
- CAR-T cell therapy research 5
- Colorectal Cancer Treatments and Studies 3
-
- Hepatitis C virus research 4
- Co-authors
- René Bruno (13 shared papers)Patrick Ip (3 shared papers)Ian Chi Kei Wong (3 shared papers)Esther Wai Yin Chan (3 shared papers)Benjamin M. Wu (11 shared papers)Emily A. Simonoff (2 shared papers)Miriam Sturkenboom (2 shared papers)David Coghill (2 shared papers)
- Journals
- CPT Pharmacometrics & Systems Pharmacology (8 papers)The Journal of Clinical Pharmacology (3 papers)Cancer Chemotherapy and Pharmacology (3 papers)The AAPS Journal (3 papers)Clinical and Translational Science (2 papers)
- Partner nations
- United StatesFranceChina
In The Last Decade
Phyllis Chan
40 papers receiving 658 citations
Peers
Comparison fields: 5 of 83
- Oncology 150
- Hepatology 42
- Gastroenterology 26
- Statistics and Probability 43
- Immunology 89
Countries citing papers authored by Phyllis Chan
This map shows the geographic impact of Phyllis Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phyllis Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phyllis Chan more than expected).
Fields of papers citing papers by Phyllis Chan
This network shows the impact of papers produced by Phyllis Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phyllis Chan. The network helps show where Phyllis Chan may publish in the future.
Co-authors
The 25 scholars most cited alongside Phyllis Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 107 | |
| 2 | 2021 | 49 | |
| 3 | 1983 | 41 | |
| 4 | 2022 | 40 | |
| 5 | 2023 | 39 | |
| 6 | 2015 | 33 | |
| 7 | 2017 | 28 | |
| 8 | 2021 | 28 | |
| 9 | 2021 | 27 | |
| 10 | 1977 | 23 | |
| 11 | 2021 | 23 | |
| 12 | 2020 | 22 | |
| 13 | 2021 | 18 | |
| 14 | 2021 | 17 | |
| 15 | 2017 | 16 | |
| 16 | 2020 | 16 | |
| 17 | 2023 | 15 | |
| 18 | 2020 | 14 | |
| 19 | 2017 | 13 | |
| 20 | 2017 | 12 |
About Phyllis Chan
Phyllis Chan is a scholar working on Oncology, Hepatology, Immunology, Radiology, Nuclear Medicine and Imaging and Psychiatry and Mental health, having authored 42 papers that have together received 695 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Biosimilars and Bioanalytical Methods (6 papers), CAR-T cell therapy research (5 papers), Attention Deficit Hyperactivity Disorder (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Hepatitis C virus research (4 papers), Statistical Methods in Clinical Trials (3 papers) and Colorectal Cancer Treatments and Studies (3 papers). The work is most often cited by research in Oncology (150 citations), Hepatology (42 citations), Gastroenterology (26 citations), Statistics and Probability (43 citations) and Immunology (89 citations). Phyllis Chan has collaborated with scholars based in United States, France and China. Frequent co-authors include René Bruno, Patrick Ip, Ian Chi Kei Wong, Esther Wai Yin Chan, Benjamin M. Wu, Emily A. Simonoff, Miriam Sturkenboom, David Coghill, K de Man and Martijn J. Schuemie. Their work appears in journals such as CPT Pharmacometrics & Systems Pharmacology, The Journal of Clinical Pharmacology, Cancer Chemotherapy and Pharmacology, The AAPS Journal and Clinical and Translational Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.